Partner Headlines - BIIB

  1. Gilead, Johnson & Johnson or Roche?

    GuruFocus
  2. Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist ...

    GuruFocus
  3. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  4. Former Leaders Show Up On New Low List; D.R. Horton Sinks Again

    IBD
  5. Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth

    IBD
  6. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD
  7. Maybe Some Good News For A Big Biotech ETF

    Benzinga
  8. Sobi to present new interim ASPIRE data at EAHAD congress suggesting ...

    Benzinga
  9. Earnings Recap For January 27

    Benzinga
  10. Apple and Boeing Earnings, Plus Oil Drag, Combine to Dent Stocks

    Benzinga
  11. Biogen's Stock Pops Following Better-Than-Expected Q4 Results

    Benzinga
  12. 10 Stocks Moving In Wednesday's Pre-Market Session

    Benzinga
  13. Earnings Scheduled For January 27, 2016

    Benzinga
  14. Big Earnings Expectations For Big Biotech

    Benzinga
  15. Biogen Ticks Up Following EU Marketing Authorization Of Benepali

    Benzinga
  16. Biogen, Samsung JV Announces Etanercept Biosimilar Referencing ...

    Benzinga
  17. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD
  18. This Week Is Paramount For Biotech Stocks

    Benzinga
  19. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus
  20. Jean Hynes Finds Her Pot of Gold

    GuruFocus
  21. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga
  22. Not All Of Clinton's Policies Are Bad For Pharmaceuticals

    Benzinga
  23. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD
  24. Early Global News: Virtual Reality Market Getting Really Big, ...

    Benzinga
  25. Sanofi chips at Biogen share

    IBD
  26. Sanofi Chipping Away At Biogen's MS Dominance

    IBD
  27. Biotechs Weaken, But These Names Have Bullish Charts

    IBD
  28. Sobi and Biogen's Elocta Approved by EC for Treatment of Haemophilia ...

    Benzinga
  29. Stocks Quietly Higher; JD.com Clears Key Resistance

    IBD
  30. PRIMECAP Sells Stake in Technology Company

    GuruFocus
  31. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus
  32. Biogen Among Murray Stahl's Holdings With Growing Earnings

    GuruFocus
  33. 10 S&P 500 Companies With Green Operations

    Benzinga
  34. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  35. Biogen's Breach Of 50-Day Line Was Clear Sell Signal

    IBD
  36. Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer

    GuruFocus
  37. Biotechs Among Stocks That Insiders Have Been Buying Lately

    Benzinga
  38. Biogen Is a Bargain

    GuruFocus
  39. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga
  40. Apple Upgraded To Buy; Amazon, McDonald's PTs Hiked

    IBD
  41. Hurricane Hillary Shifts Left, Slamming More Stocks

    IBD
  42. Biogen tops Q3, will cut jobs

    IBD
  43. Biogen Volatile After Q3 Beat, Raised Guidance And Disappointing ...

    Benzinga
  44. Why Biogen Stock Is Having A Huge Day

    Benzinga
  45. Biogen Beats Q3 Views, Cuts Workforce, Lifts Guidance

    IBD
  46. Early Gains Fizzle, Turn Mixed; Biogen, Ferrari Rise

    IBD
  47. Benzinga's Top #PreMarket Gainers

    Benzinga
  48. Earnings Scheduled For October 21, 2015

    Benzinga
  49. Fast Money Picks For October 20

    Benzinga
  50. Stock Week Ahead: Housing Data, Broad-Based Earnings Line Up

    Benzinga
  51. Why Rental Rates At Biotech Labs Are Skyrocketing

    IBD
  52. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  53. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  54. Market Has Overreacted in Biogen

    GuruFocus
  55. Frank Sands' Undervalued Holdings With Growing EPS

    GuruFocus
  56. Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20

    IBD
  57. Stocks Inch Up; Oil Gains Ease; Alcoa, Tesla, Gap Stumble

    IBD
  58. Gilead, Biotechs Were TPP Losers; Boeing Is Upbeat

    IBD
  59. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD
  60. Will Fund Managers Pump Up Edwards To New Breakout?

    IBD
  61. DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq

    IBD
  62. Trans Pacific Trade Pact Finally Agreed

    Benzinga
  63. Stock Leadership Has Dumped Medical, Turned Diverse

    IBD
  64. Fast Money Traders Share The Stocks They Would Buy In Fourth ...

    Benzinga
  65. Stocks Rally, Will Gains Hold? Biotechs Try Second Rebound

    IBD
  66. Stocks Mixed In Late Trade; Post Falls More

    IBD
  67. Wall Street Wobbles as Stocks Try to Rebound

    FoxBusiness
  68. Roche Drug Scores A Hit Against Stubborn Form Of MS

    IBD
  69. Can Valeant Heal After Clinton Price-Gouging Tweet?

    IBD
  70. Can Valeant Heal After Clinton Price Gouging Tweet?

    IBD
  71. Biogen Approaches Support Levels In $290 Handle

    Benzinga
  72. Biotechs Are Getting Killed Because Of Hillary Clinton's Response ...

    Benzinga
  73. The Undervalued Stocks Among Richard Snow's Recent Buys

    GuruFocus
  74. Goldman Sachs' Stock Picks if Rates Rise

    FoxBusiness
  75. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  76. Biogen Licenses Mitsubishi Tanabe Pharma's MT-1303 for Autoimmune ...

    Benzinga
  77. Biogen: 'A Nice Little Trade' Or Heading To New Lows?

    Benzinga
  78. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    Benzinga
  79. The Other Bearish Biotech ETF Is Looking Groovy, Too

    Benzinga
  80. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders ...

    GuruFocus
  81. Using ETFs To Run Your Own Hedge Fund

    Benzinga
  82. Morning Market Gainers

    Benzinga
  83. Benzinga's Top #PreMarket Gainers

    Benzinga
  84. AGTC Release Confirms Strategic Collaboration With Biogen Effective ...

    Benzinga
  85. The Best Companies of the Pharmaceuticals Industry - August 2 ...

    GuruFocus
  86. Benzinga's Top Initiations

    Benzinga
  87. IBD's Big Cap 20 Stocks Offer Refuge In Choppy Market

    IBD
  88. Vanguard Health Care Fund Buys Two New Stakes in Second Quarter

    GuruFocus
  89. These Two Biotechs Boast Big EPS Growth Rates

    IBD
  90. What Company Will Be Fastest Growing Big-Cap Biotech?

    IBD
  91. Regeneron Tops 3 Med Stocks Moving Big On Earnings

    IBD
  92. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD
  93. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD
  94. Which Big-Cap Stocks Are Defying Market Pressure?

    IBD
  95. Caution Continues In Options Market This Week

    Benzinga
  96. A Big Day For Biotech And It's Not Going So Well

    Benzinga
  97. Benzinga's Volume Movers

    Benzinga
  98. A Look Ahead: Biotech And Energy ETFs To Watch This Week

    Benzinga
  99. Benzinga's Top Downgrades

    Benzinga
  100. Biogen Enters Collaboration with the Parkinson's Institute and ...

    Benzinga
Trading Center